Physician

Mark J Zucker, MD

According to 2025 Medicare claims, Mark Zucker, MD (NPI: 1356319180) practices advanced heart failure and transplant cardiology in the Camden, NJ market, with the plurality of this provider's patient population coming from Gloucester, NJ. This provider's primary affiliated billing organization is KENNEDY MEDICAL GROUP PRACTICE, P.C. (NPI: 1952726796; TIN: 461420853) and primary practice location at 07960-9446. Zucker is affiliated with the Atlantic ACO (ACO ID: A1026), RWJBH Accountable Care, LLC (ACO ID: A1247), Einstein Care Partners, LLC (ACO ID: A3671), and Vytalize Health 9 ACO LLC (ACO ID: D0313), participating under both the MSSP and REACH models.

Zucker's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 164 traditional Medicare patients, billed 579 HCPCS/CPT codes, and received $48,818 in Medicare payments. The top billing code was 99205 (New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more). Part D data shows 1,205 prescription claims across 172 beneficiaries totaling $1,943,886 in drug costs, led by Vyndamax (Tafamidis). DME data shows 151 claims. Open Payments data shows 52 records totaling $26,955. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has declined steadily, from $106,317 to $48,818. In contrast, Part D prescription costs have moved sharply higher in recent years, from $680,037 to $1,943,886. For DME billing, reported payments started with an early spike, then settled into a lower baseline, moving from $130,125 to $15,083.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	397	1,425	$106,317
2016	400	987	$85,394
2017	350	760	$70,672
2018	341	787	$68,605
2019	268	535	$42,926
2020	N/R	N/R	N/R
2021	62	216	$21,094
2022	138	853	$74,560
2023	182	679	$58,484
2024	164	579	$48,818

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	378	5,602	$680,037
2016	396	5,425	$694,362
2017	411	4,849	$662,532
2018	409	4,512	$720,210
2019	367	3,394	$967,799
2020	165	652	$319,757
2021	35	163	$29,313
2022	84	759	$639,810
2023	115	1,007	$1,920,119
2024	172	1,205	$1,943,886

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	302	3,420	$1,976,309
2016	195	2,112	$844,004
2017	195	1,890	$118,153
2018	274	2,641	$168,698
2019	230	2,346	$146,308
2020	67	1,047	$96,261
2021	N/R	454	$48,696
2022	N/R	502	$50,378
2023	N/R	426	$54,835
2024	N/R	151	$28,519

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99205	New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more	32	32	$173
99215	Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more	75	122	$141
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	103	187	$97
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	51	75	$14
93000	Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report	39	42	$11

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Vyndamax	Tafamidis	33	1,290	$953,908
Camzyos	Mavacamten	30	870	$235,297
Entresto	Sacubitril/Valsartan	80	4,509	$95,640
Verquvo	Vericiguat	53	2,490	$53,344
Eliquis	Apixaban	45	2,580	$48,648

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
J7508	Tacrolimus, extended release, (astagraf xl), oral, 0.1 mg	N	N/R	21	$22,577
A4222	Infusion supplies for external drug infusion pump, per cassette or bag (list drugs separately)	N	N/R	14	$3,164
J2260	Injection, milrinone lactate, 5 mg	N	N/R	14	$1,065
Q0511	Pharmacy supply fee for oral anti-cancer, oral anti-emetic or immunosuppressive drug(s); for the first prescription in a 30-day period	N	N/R	31	$583
Q0512	Pharmacy supply fee for oral anti-cancer, oral anti-emetic or immunosuppressive drug(s); for a subsequent prescription in a 30-day period	N	N/R	32	$464

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	52	$26,955	Merck Sharp & Dohme LLC
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Mark J. Zucker, MD?

Tedicare shows public-source Medicare data for Mark J. Zucker, MD (NPI 1356319180), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Mark J. Zucker, MD have ACO affiliation data?

Mark J. Zucker, MD is shown with ACO affiliation data for Atlantic ACO (MSSP, ACO ID A1026), RWJBH Accountable Care, LLC (MSSP, ACO ID A1247), Einstein Care Partners, LLC (MSSP, ACO ID A3671), and Vytalize Health 9 ACO LLC (REACH, ACO ID D0313).

What billing organization is linked to Mark J. Zucker, MD?

Mark J. Zucker, MD is linked to KENNEDY MEDICAL GROUP PRACTICE, P.C. (billing NPI 1952726796) in the available physician profile data.

Does Mark J. Zucker, MD have Open Payments data?

Mark J. Zucker, MD has 52 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.